PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

HEOR

Health economics and outcomes research, real-world evidence, comparative effectiveness modeling, and indirect treatment comparisons.

1 article·Lives underPricing & Access Evidence·Last updated 2026-08-08

Policy· August 8, 2026 · 14 min read

EU Joint Clinical Assessments under the HTA Regulation: 2026 market access guide

By Ran Chen#EU HTA #Joint Clinical Assessment #Market Access